CliffBio
small molecule

PHOTREXA VISCOUS IN DEXTRAN 20%/PHOTREXA

RIBOFLAVIN 5'-PHOSPHATE SODIUM

Loss of exclusivity—loss of exclusivity
CompanyGlaukos →See this company's full patent-cliff portfolio

Drug detail

Brand namePHOTREXA VISCOUS IN DEXTRAN 20%/PHOTREXA
Active ingredientRIBOFLAVIN 5'-PHOSPHATE SODIUM
StrengthEQ 0.146% BASE/ML;EQ 0.146% BASE/ML
Dosage formSOLUTION/DROPS
RouteOPHTHALMIC
ModalitySmall molecule
FDA approvalApril 2016
Marketing statusRX

More from Glaukos

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

PHOTREXA VISCOUS IN DEXTRAN 20%/PHOTREXA patent cliff — loss of exclusivity — | CliffBio